J Med Microbiol 55 (2006), 1461-1475; DOI: 10.1099/jmm.0.46697-0
© 2006 Society for General Microbiology
ISSN 1473-5644
Treatment of plague: promising alternatives to antibiotics
Andrey P. Anisimov1 and
Kingsley K. Amoako2
1 Laboratory for Plague Microbiology, Department of Infectious Diseases, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Serpukhov District, Moscow Region, Russia
2 Canadian Food Inspection Agency, Animal Diseases Research Institute, P.O. 640, Township Road 9-1, Lethbridge, AB T1J 3Z4, Canada
Correspondence
Andrey P. Anisimov
anisimov{at}obolensk.org
Plague still poses a significant threat to human health, and interest has been renewed recently in the possible use of Yersinia pestis as a biological weapon by terrorists. The septicaemic and pneumonic forms are always lethal if untreated. Attempts to treat this deadly disease date back to the era of global pandemics, when various methods were explored. The successful isolation of the plague pathogen led to the beginning of more scientific approaches to the treatment and cure of plague. This subsequently led to specific antibiotic prophylaxis and therapy for Y. pestis. The use of antibiotics such as tetracycline and streptomycin for the treatment of plague has been embraced by the World Health Organization Expert Committee on Plague as the gold standard treatment. However, concerns regarding the development of antibiotic-resistant Y. pestis strains have led to the exploration of alternatives to antibiotics. Several investigators have looked into the use of alternatives, such as immunotherapy, non-pathogen-specific immunomodulatory therapy, phage therapy, bacteriocin therapy, and treatment with inhibitors of virulence factors. The alternative therapies reported in this review should be further investigated by comprehensive studies of their clinical application for the treatment of plague.
Abbreviations: DIC, diffuse intravascular coagulation; WHO, World Health Organization.
This article has been cited by other articles:

|
 |

|
 |
 
P. A. Arlen, M. Singleton, J. J. Adamovicz, Y. Ding, A. Davoodi-Semiromi, and H. Daniell
Effective Plague Vaccination via Oral Delivery of Plant Cells Expressing F1-V Antigens in Chloroplasts
Infect. Immun.,
August 1, 2008;
76(8):
3640 - 3650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Schwudke, A. Ergin, K. Michael, S. Volkmar, B. Appel, D. Knabner, A. Konietzny, and E. Strauch
Broad-Host-Range Yersinia Phage PY100: Genome Sequence, Proteome Analysis of Virions, and DNA Packaging Strategy
J. Bacteriol.,
January 1, 2008;
190(1):
332 - 342.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2006 Society for General Microbiology.